Natarajan Sethuraman

Insider Reports History

Entity
Individual
Location
6 Tide Street, Boston, MA
Signature
/s/ Jared Cohen, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Natarajan Sethuraman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Entrada Therapeutics, Inc. President, Research & Develop. Common Stock 145K $2.92M $20.15 Dec 3, 2024 Direct
Entrada Therapeutics, Inc. President, Research & Develop. Stock Option (Right to Buy) 66.8K Mar 1, 2024 Direct

Insider Reports Filed by Natarajan Sethuraman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TRDA Entrada Therapeutics, Inc. Nov 29, 2024 3 -$321K 4 Dec 3, 2024 President, Research & Develop.
TRDA Entrada Therapeutics, Inc. Nov 11, 2024 2 -$82.3K 4 Nov 13, 2024 President, Research & Develop.
TRDA Entrada Therapeutics, Inc. Nov 4, 2024 4 -$339K 4 Nov 6, 2024 President, Research & Develop.
TRDA Entrada Therapeutics, Inc. Oct 16, 2024 1 -$10.8K 4 Oct 18, 2024 President, Research & Develop.
TRDA Entrada Therapeutics, Inc. Sep 6, 2024 2 -$49K 4 Sep 10, 2024 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Sep 3, 2024 5 -$27.5K 4 Sep 5, 2024 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Jul 12, 2024 2 -$22.3K 4 Jul 16, 2024 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. May 16, 2024 3 -$288K 4 May 20, 2024 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Mar 1, 2024 5 -$28.3K 4 Mar 5, 2024 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Sep 1, 2023 3 -$6.49K 4 Sep 6, 2023 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Jul 10, 2023 2 -$322K 4 Jul 12, 2023 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Apr 17, 2023 1 -$71.3K 4 Apr 19, 2023 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Mar 1, 2023 2 $0 4/A Apr 19, 2023 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Sep 1, 2022 1 $0 4 Sep 6, 2022 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Jul 1, 2022 1 $0 4 Jul 6, 2022 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Mar 1, 2022 2 $0 4 Mar 3, 2022 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Oct 28, 2021 1 $0 4 Nov 1, 2021 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Oct 28, 2021 0 $0 3 Oct 28, 2021 Chief Scientific Officer